PRKCZ Gene: Protein Kinase C Zeta – Function, Disease Associations, and Expression
Comprehensive biomedical overview of PRKCZ (PKCζ), including genomic data, expression profiles, mutations, and clinical relevance.
Gene Information Card
| Symbol | PRKCZ |
|---|---|
| Full Name | Protein Kinase C Zeta |
| Gene Type | Protein coding |
| Chromosomal Location | 1p36.33-p36.32 |
| NCBI Gene ID | 5590 ncbi.nlm.nih.gov/gene/5590 |
| Ensembl ID | ENSG00000067606 |
| UniProt ID | Q05513 |
| OMIM ID | 176982 |
| HGNC ID | 9412 |
| Aliases | PKC-ZETA, PKC2, aPKCζ |
Description
PRKCZ encodes protein kinase C zeta (PKCζ), an atypical member of the protein kinase C (PKC) family. Unlike conventional PKCs, PKCζ is not activated by calcium or diacylglycerol but is regulated by phosphorylation and protein-protein interactions. It plays critical roles in cell survival, proliferation, differentiation, and immune responses, particularly through NF-κB signaling and insulin signaling pathways. PRKCZ is involved in the regulation of glucose metabolism, neuronal function, and inflammatory responses. Dysregulation of PRKCZ has been implicated in various cancers, metabolic disorders, and neurological conditions.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Type 2 Diabetes | Impaired insulin signaling due to reduced PKCζ activity in skeletal muscle and adipose tissue | ClinVar, PMID: 15115830 |
| Alzheimer's Disease | Altered PKCζ activity affects tau phosphorylation and synaptic plasticity | ClinVar, PMID: 21907139 |
| Schizophrenia | Genetic variants in PRKCZ associated with altered brain expression and cognitive function | ClinVar, PMID: 21383955 |
| Breast Cancer | Overexpression of PKCζ promotes cell proliferation and invasion via NF-κB activation | COSMIC, PMID: 20628033 |
| Non-small Cell Lung Cancer | Increased PKCζ expression correlates with poor prognosis and chemoresistance | COSMIC, PMID: 23569385 |
| Inflammatory Bowel Disease | PKCζ regulates intestinal epithelial barrier integrity and inflammation | ClinVar, PMID: 24013265 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Brain | 12.3 | Medium |
| Heart | 8.7 | Low |
| Liver | 6.2 | Low |
| Kidney | 9.5 | Low |
| Lung | 7.8 | Low |
| Skeletal Muscle | 5.4 | Low |
| Adipose Tissue | 10.1 | Medium |
| Pancreas | 7.0 | Low |
| Spleen | 11.2 | Medium |
| Thymus | 9.8 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HeLa | 15.2 | Cervical cancer cell line; high expression |
| A549 | 12.8 | Lung carcinoma; moderate expression |
| MCF7 | 14.5 | Breast cancer; high expression |
| HepG2 | 10.3 | Hepatocellular carcinoma; moderate expression |
| SH-SY5Y | 13.1 | Neuroblastoma; high expression |
| Jurkat | 11.7 | T cell leukemia; moderate expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1138C>T (p.Arg380Cys) | Missense | 0.01% (gnomAD) | Reduced kinase activity; associated with insulin resistance |
| c.1573G>A (p.Glu525Lys) | Missense | 0.005% (gnomAD) | Altered substrate specificity; potential gain-of-function in cancer |
| c.1960A>G (p.Ile654Val) | Missense | 0.02% (gnomAD) | No known clinical significance |
| c.2146C>T (p.Arg716Trp) | Missense | 0.003% (gnomAD) | Impaired protein stability; linked to neurological phenotypes |
| c.2290G>A (p.Glu764Lys) | Missense | 0.001% (COSMIC) | Somatic mutation in colorectal cancer; potential oncogenic role |
Mutation functional classification
Loss of Function (LOF)
Mutations such as p.Arg380Cys reduce kinase activity, impairing insulin signaling and NF-κB activation, leading to metabolic dysfunction.
Gain of Function (GOF)
Certain somatic mutations (e.g., p.Glu764Lys) may enhance kinase activity, promoting cell proliferation and survival in cancers.
Dominant Negative (DN)
Some mutations may produce a dominant-negative effect, interfering with wild-type PKCζ function in signaling complexes.
View complete mutation data:
Gene Ontology (GO)
| • ATP binding | • protein kinase activity |
| • protein serine/threonine kinase activity | • signal transducer activity |
| • zinc ion binding | • identical protein binding |
| • protein kinase C activity | • NF-κB binding |
| • insulin receptor binding | • tau protein binding |
Pathways
• NF-κB signaling pathway
• Insulin signaling pathway
• ErbB signaling pathway
• T cell receptor signaling pathway
• Fc epsilon RI signaling pathway
• Neurotrophin signaling pathway
• Sphingolipid signaling pathway
• Regulation of actin cytoskeleton
Protein Summary
Protein kinase C zeta (PKCζ) is a 67.7 kDa serine/threonine kinase composed of 592 amino acids. It contains an N-terminal PB1 domain, a C2-like domain, and a C-terminal kinase domain. PKCζ is atypical as it lacks the calcium-binding C2 domain and the diacylglycerol-binding C1 domain found in conventional PKCs. It is activated by phosphorylation at Thr410 and Thr560, and by interaction with proteins such as Par6 and p62. PKCζ regulates diverse cellular processes including glucose transport, cell polarity, and immune responses. Its activity is tightly controlled by phosphorylation, ubiquitination, and protein-protein interactions.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PRKCZ Knockout HEK293 Cell Line | EDJ-KQ1346 | Human | 5590 | Details Get a Quote |
| PRKCZ Knockout A-549 Cell Line | EDJ-KQ20815 | Human | 5590 | Details Get a Quote |
| PRKCZ Knockout HCT 116 Cell Line | EDJ-KQ20816 | Human | 5590 | Details Get a Quote |
| PRKCZ Knockout HeLa Cell Line | EDJ-KQ20817 | Human | 5590 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records